Amphastar Pharma (NASDAQ: AMPH) reported Q2 EPS of $0.91, $0.28 better than the analyst estimate of $0.63. Revenue for the quarter came in at $183.9 million versus the consensus estimate of $179.71 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.